Clinical studies with calcium antagonists in asthma.

P. Barnes
DOI: https://doi.org/10.1111/J.1365-2125.1985.TB02815.X
1985-04-01
British Journal of Clinical Pharmacology
Abstract:Airway obstruction in asthma involves not only contraction of airway smooth muscle (which may involve vagal neural reflexes), but also plugging of the airways with viscous mucus, airway mucosal oedema produced by bronchial microvascular leakiness, and by inflammatory cell infiltration of the airway wall (Barnes, 1983a). Since contraction of airway smooth muslle, secretion of mucus and inflammatory mediators, neurotransmission and chemotaxis all depend on the movement of calcium ions into cells, this has prompted the suggestion that drugs which block calcium ion influx (calcium antagonists) might be beneficial in the treatment of asthma. It has even been suggested that excessive permeability of airway cells to calcium ions might be the underlying mechanism of bronchial hyperreactivity and asthma (Middleton, 1980). There has recently been considerable interest in the use of calcium antagonists in asthma (Bames, 1983b; Fanta & Drazen, 1983; Middleton, 1983), and the purpose of this paper is to review the results of these clinical studies.
What problem does this paper attempt to address?